发明人朱建伟,马晓峰,钱学锋. "Method for the Synthesis of Ceritinib Impurity 35" [P]. 中国发明专利, 专利号 CN 110268689 A, 授权公告日 2021-02-03.
发明人冯建国,唐晓军,王建平. "A Process for Preparing High-Purity Ceritinib Impurity 35" [P]. 中国发明专利, 专利号 CN 110838523 A, 授权公告日 2021-02-02.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质35 in Pharmaceutical Formulations". J. Chromatogr. A, 2019, 2438, (8), 6397-6408.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质35 as an Impurity". Talanta, 2016, 1841, 7517-7521.
Zhang Y, Li Q, Chen T. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 35 Using HRMS and NMR". Anal. Methods, 2016, 555, 4010-4026.
Mueller T, Schmidt R K. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质35 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2011, 1967, (6), 9331-9358.